@inproceedings{inproceedings, title = {{Ixazomib, Thalidomide and Dexamethasone Is an Effective and Well Tolerated Re-Induction Regimen Leading to Salvage Autologous Stem Cell Transplantation (sASCT): Results from the Re-Induction Interim Analysis of UK-MRA Myeloma XII (ACCoRD) Trial}}, publisher = {{American Society of Hematology}}, url = {{}}, year = {{2018}}, month = {{11}}, author = {{Cook G and Parrish C and Yong K and Cavenagh J and Snowden JA and Drayson MT and Garg M and Cairns D and Ashcroft J and Striha A and Hockaday A et al}}, doi = {{10.1182/blood-2018-99-112116}}, volume = {{132}}, journal = {{Blood}}, issue = {{Supplement 1}}, pages = {{255-255}}, note = {{Accessed on 2025/05/24}}}